The Q4 2025 Pharma Biotools VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.
As innovation shifts from software to science-driven ventures, investors must rethink risk, prioritising technical uncertainty, IP-led moats, and team capability to back deep tech shaping […]
In an era of rapid capital deployment and surface-level conviction, few investors in Asia combine founder empathy with institutional discipline as consistently as Will Klippgen. […]